Page last updated: 2024-12-06
mergocriptine
Description
Mergocriptine is an ergot alkaloid with a complex chemical structure. It is synthesized from the fungus Claviceps purpurea, which grows on rye and other grains. Mergocriptine is known for its dopamine agonist properties, meaning it binds to and activates dopamine receptors in the brain. This action leads to various pharmacological effects, including the inhibition of prolactin secretion, reduction of pituitary tumors, and treatment of Parkinson's disease. Its importance lies in its therapeutic potential for conditions related to dopamine dysfunction. Researchers study mergocriptine to understand its mechanisms of action, explore its potential as a drug for various neurological disorders, and investigate its safety and efficacy. The complex structure and diverse effects of mergocriptine make it an interesting subject of scientific investigation.'
mergocriptine: structure given in first source; RN given refers to (5'alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 54803 |
CHEMBL ID | 2105887 |
SCHEMBL ID | 2109602 |
MeSH ID | M0184695 |
Synonyms (19)
Synonym |
mergocriptine |
81968-16-3 |
mergocriptina [spanish] |
mergocriptine [inn] |
2-methyl-alpha-ergocryptine |
mergocriptinum [latin] |
mergocriptinum |
mergocriptina |
unii-vxd47yrh4q |
vxd47yrh4q , |
2-methyl-.alpha.-ergocryptine |
cbm36-733 |
cbm 36-733 |
CHEMBL2105887 |
SCHEMBL2109602 |
(6ar,9r)-n-[(1s,2s,4r,7s)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-5,7-dimethyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide |
Q27292072 |
DTXSID501002339 |
n-[10b-hydroxy-5-(2-methylpropyl)-3,6-dioxo-2-(propan-2-yl)octahydro-8h-[1,3]oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-2,6-dimethyl-9,10-didehydroergoline-8-carboximidic acid |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |